• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.36% Nasdaq Up0.45%

    More On TELK

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    MABVAX THERAPEUTICS (TELK)

    -Other OTC
    5.50 0.00(0.00%) Oct 9
    Add to Portfolio
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):N/A
    Mean Recommendation (last week):N/A
    Change:N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:N/A
    Median Target:N/A
    High Target:N/A
    Low Target:N/A
    No. of Brokers:N/A

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Sep 28, 2007BMO Capital MarketsInitiated Market Perform
    Jun 5, 2007WachoviaDowngradeOutperformMkt Perform
    Apr 17, 2007Janney Mntgmy ScottUpgradeSellNeutral
    Apr 17, 2007Stifel NicolausUpgradeSellHold
    Jan 3, 2007Bear StearnsDowngradeOutperformPeer Perform
    Dec 27, 2006Thomas WeiselDowngradeMarket WeightUnderweight
    Dec 27, 2006UBSDowngradeBuyNeutral
    Dec 27, 2006Needham & CoDowngradeStrong BuyHold
    Dec 26, 2006Janney Mntgmy ScottDowngradeBuySell
    Dec 26, 2006Stifel NicolausDowngradeBuySell

    More Upgrades & Downgrades for TELK

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy
    Buy
    Hold
    Underperform
    Sell

    Data provided by Thomson/First Call


    Currency in USD.